Quidel reported $606.8M in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
Agilent USD 1.43B 2M Jun/2026
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Bruker USD 790.5M 21.6M Sep/2026
Cerus USD 34.78M 2.98M Dec/2024
Charles River Laboratories USD 3.23B 387.38M Sep/2026
Danaher USD 53.62B 1.04B Sep/2026
Haemonetics USD 145.79M 448K Sep/2026
Illumina USD 525M 374M Sep/2026
IQVIA Holdings USD 3.82B 2.05B Sep/2026
Merit Medical Systems USD 358.44M 20.72M Jun/2026
Mettler Toledo International USD 77.66M 662.11M Sep/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Neogen USD 224.6M 2.4M Jun/2026
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quidel USD 606.8M 39.4M Sep/2026
Revvity USD 604.27M 719K Sep/2026
STAAR Surgical USD 77.95M 5.48M Sep/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Waters USD 527M 592M Jun/2026